| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |